Combination Treatment in Ulcerative Colitis using 5-Aminosalysilic Acid (5-ASA) and Polysaccharide Peptide of Indonesian Ganoderma lucidum Mycelium Extract
Background: Inflammatory bowel disease (IBD) is idiopathic disease characterized by chronic inflammation of the gastrointestinal tract. Polysaccharide peptide of Ganoderma lucidum mycelium extract (PPGL) is considerably a good option for adjunctive therapy of IBD. This study aims to evaluate the be...
Main Authors: | Marcellus Simadibrata, Aditya Rachman, Felix Budimutiar, Paulus Simadibrata, Murdani Abdullah, Raja Mangatur Haloho, Anthony Eka Wijaya, Batara Bisuk, Shabrina Maharani, Dewi Mustikarani, Daniel Martin Simadibrata, Peter Sugita |
---|---|
Format: | Article |
Language: | English |
Published: |
Interna Publishing
2023-04-01
|
Series: | The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy |
Subjects: | |
Online Access: | https://www.ina-jghe.com/index.php/jghe/article/view/899 |
Similar Items
-
The Role of β-1.3/1.6-D-Glucan From Ganoderma lucidum Mycelium Extract in Ulcerative Colitis
by: Marcellus Simadibrata, et al.
Published: (2022-01-01) -
Bioactivity of Ganoderma lucidum and optimization of mycelial fermentation conditions
by: Li Zengmei, et al.
Published: (2023-01-01) -
ANTIMICROBIAL PROPERTIES OF MYCELIUM AND BASIDIOCARPS OF GANODERMA LUCIDUM (СURTIS) P. KARST.
by: О. Ю. Зінченко, et al.
Published: (2018-06-01) -
Does Ganoderma lucidum reduce obesity?
by: Ameneh Marzban, et al.
Published: (2022-11-01) -
Ganoderma lucidum and Professor Zhi-Bin Lin
by: Xiao-Ling eZhu, et al.
Published: (2012-03-01)